Cegedim SA (LON:0DYQ)
London · Delayed Price · Currency is GBP · Price in EUR 10.18
-0.02 (-0.20%)
At close: Sep 12, 2025
Cegedim Market Cap
Cegedim has a market cap or net worth of 120.98 million as of September 15, 2025. Its market cap has decreased by -17.68% in one year.
Market Cap
120.98M
Enterprise Value
375.63M
Revenue
541.25M
Ranking
n/a
PE Ratio
n/a
Stock Price
10.18
Market Cap Chart
Since November 7, 1995, Cegedim's market cap has increased from 95.61M to 120.98M, an increase of 26.54%. That is a compound annual growth rate of 0.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 120.97M | -16.33% |
| Dec 31, 2024 | 144.58M | -31.60% |
| Dec 29, 2023 | 211.37M | 19.82% |
| Dec 30, 2022 | 176.41M | -36.57% |
| Dec 31, 2021 | 278.10M | -11.96% |
| Dec 31, 2020 | 315.88M | -7.28% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 182.89B |
| GSK plc | 60.53B |
| Haleon | 32.39B |
| Smith & Nephew | 12.20B |
| ConvaTec Group | 4.78B |
| Hikma Pharmaceuticals | 3.61B |
| HUTCHMED (China) | 2.23B |
| Genus | 1.72B |